JD Health International Inc.
JDHIY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.23 | 0.11 | -4.15 | 1.47 |
| FCF Yield | 4.91% | 4.13% | 1.72% | 1.98% |
| EV / EBITDA | 12.94 | 110.59 | 204.71 | -156.66 |
| Quality | ||||
| ROIC | 2.29% | 1.01% | 0.98% | -2.55% |
| Gross Margin | 22.88% | 22.17% | 21.16% | 23.46% |
| Cash Conversion Ratio | 1.04 | 2.15 | 15.41 | -3.20 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.56% | 20.38% | 34.10% | 41.45% |
| Free Cash Flow Growth | -5.50% | 24.87% | 24.71% | -20.44% |
| Safety | ||||
| Net Debt / EBITDA | -4.46 | -17.27 | -19.62 | 20.49 |
| Interest Coverage | 180.47 | 66.51 | 88.26 | -142.88 |
| Efficiency | ||||
| Inventory Turnover | 7.68 | 8.19 | 6.14 | 7.72 |
| Cash Conversion Cycle | -33.77 | -35.18 | -29.97 | -33.03 |